riliprubart, -, riliprubart placebo solution for injection in prefilled pen, placebo matching IVIg, riliprubart, riliprubart placebo solution for injection in vial, -
EFC18156
Phase 3 small_molecule active
Quick answer
riliprubart, -, riliprubart placebo solution for injection in prefilled pen, placebo matching IVIg, riliprubart, riliprubart placebo solution for injection in vial, - for Chronic Inflammatory Demyelinating Polyneuropathy is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Chronic Inflammatory Demyelinating Polyneuropathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active